Table 5.
Scores from assessment of relevant tissues adjacent to the treatment area including inflammation, fibrosis, calcification and pancreatic and lymph node response (Mean ± SD, median and incidence) of adjacent tissue assessments
| Parameter | Day 90 treated | |||
|---|---|---|---|---|
| CHA (n = 5) | LRA and RRA (n = 10) | |||
| Inflammation | 0.03 ± 0.08 | 20% | 0.00 ± 0.00 | 0% |
| 0.00 | 0.00 | |||
| Fibrosis | 1.19 ± 0.69 | 100% | 0.42 ± 0.36 | 70% |
| 1.33 | 0.45 | |||
| Calcification | 0.24 ± 0.43 | 40% | 0.00 ± 0.00 | 0% |
| 0.00 | 0.00 | |||
| Pancreatic response | 0.22 ± 0.21 | 75% | NA ± NA | NA |
| 0.19 | NA | |||
| Lymph node response | 0.00 ± 0.00 | 0% | 0.00 ± 0.00 | 0% |
| 0.00 | 0.00 | |||
CHA common hepatic artery, LRA left renal artery, RRA right renal artery, NA not applicable
Adjacent tissue assessment: 0 = none; 1 = (minimal) < 20 cells/40 × HDF—changes barely perceptible; 2 = (mild) 21–100 cells/40 × HDF—changes present but involves a small amount of tissue; 3 = (moderate) 101–150 cells/40 × HDF—changes clearly visible and involves a significant proportion of the tissue; 4 = (marked) > 150 cells/40 × HDF—changes prominently visible and involves a major portion of the tissue